HealthMore in Health→
Study Finds Pharma Ties Among FDA Patient Representatives
Key Takeaways
- Nearly 40% of reviewed FDA advisory meetings included a patient or consumer representative tied to a pharma-funded advocacy group.
- The review covered nearly 240 meetings of 12 FDA advisory committees from 2013 to 2022.
- The study raises disclosure concerns but does not establish that affiliations altered committee decisions.
DE
DT Editorial Team··via medicalxpress.com
